Clinical Trials Directory

Trials / Unknown

UnknownNCT01789294

Clinical Management of Childhood Intestinal Lymphoid Nodular Hyperplasia

CLINICAL MANAGEMENT OF CHILDHOOD INTESTINAL LYMPHOID NODULAR HYPERPLASIA: A RANDOMIZED CONTROLLED CLINICAL TRIAL.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
270 (estimated)
Sponsor
Azienda Policlinico Umberto I · Academic / Other
Sex
All
Age
6 Months – 18 Years
Healthy volunteers
Not accepted

Summary

Aim of this prospective, parallel multi-arm, randomized, clinical trial, was to compare the clinical outcome of patients Methods.We recruited children who undergone diagnostic colonoscopy in Umberto I Pediatric Department (Rome, Italy) from 2008 to 2010. Eligibility criteria were: 1) only demonstration of LNH; 2) no concomitant disease; 3) no treatment assumed since the clinical onset. Patients were allocated 1:1:1 to dietetic (Group A) vs mesalamine (Group B) vs no treatment (Group C) for a 8-weeks period. Skin prick tests and patch test for common foods, and symptoms scoring at baseline and follow up have been performed by blinded clinicians. Chi-square test for trend was used to compare the frequency of symptoms score improvement (\>1 point) among groups. The association of baseline features of patients with the clinical response was estimated by frequency analysis.

Detailed description

Lymphoid nodular hyperplasia (LNH) of the lower gastrointestinal tract is a common finding in pediatric colonoscopies, whose clinical significance is not yet been clearly established. Although initially considered to be a normal, age-related variant, some authors recently suggested to regard LNH as a marker of food allergy (FA).

Conditions

Interventions

TypeNameDescription
DRUGMesalamineA standard 50 mg/kg/die daily dose of oral mesalamine was prescribed by Pediatric Gastroenterologists, which informed parents of potential side effects. Whether the drug was not well tolerated, patients were drop out. Treatment was discontinued at time 1 to look for symptom recurrence.
BEHAVIORALDIETDietetic avoidance of cow's milk and egg, plus foods eventually detected by skin tests, was prescribed by Pediatric Allergologists. To ensure the correct adherence to diet with no nutritional impairment, a scheme of admitted foods and an appropriate calcium supplement dose were given to patients.

Timeline

Start date
2008-11-01
Primary completion
2013-02-01
Completion
2013-03-01
First posted
2013-02-12
Last updated
2013-02-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01789294. Inclusion in this directory is not an endorsement.